Philip Morris Unveils Value Plan 2030+ for Sustainable Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy PM?
Source: Newsfilter
- Sustainability Strategy: Philip Morris International (PMI) released its 2025 Value Report, introducing the Value Plan 2030+ aimed at driving the company's transformation towards a smoke-free future through continuous innovation and capital allocation, which is expected to significantly enhance its competitiveness in global markets.
- Strong Financial Performance: PMI's smoke-free products achieved net revenues of $16.9 billion in 2025, representing 41.5% of total annual net revenues, indicating substantial market share growth during the transformation and reinforcing its leadership in consumer health.
- Reduced Environmental Impact: PMI achieved a 46% reduction in greenhouse gas emissions compared to 2019 and reached carbon neutrality in its direct operations by 2025, demonstrating proactive efforts in addressing climate change and enhancing its sustainable brand image.
- Commitment to Social Responsibility: By the end of 2025, 99.6% of contracted farmers achieved a living income, showcasing PMI's success in promoting agricultural sustainability and social responsibility, which further enhances trust and brand loyalty among stakeholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PM
Wall Street analysts forecast PM stock price to rise
11 Analyst Rating
8 Buy
3 Hold
0 Sell
Moderate Buy
Current: 163.540
Low
175.00
Averages
191.95
High
210.00
Current: 163.540
Low
175.00
Averages
191.95
High
210.00
About PM
Philip Morris International Inc. is an international tobacco company. The Company’s product portfolio primarily consists of cigarettes and smoke-free products. Its smoke-free business (SFB) also includes wellness and healthcare products, as well as consumer accessories, such as lighters and matches. The Company’s segments include Europe Region; South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region (SSEA, CIS & MEA); East Asia, Australia & PMI Global Travel Retail (EA, AU & PMI GTR), and Americas Region. The Company's brands include Marlboro, HEETS, IQOS, IQOS ILUMA, TEREA, VEEV and ZYN. Its IQOS smoke-free product brand portfolio includes heated tobacco and nicotine-containing vapor products. Its international cigarette brands are Chesterfield, L&M, and Philip Morris. It also owns a number of local cigarette brands, such as Dji Sam Soe and Sampoerna A in Indonesia, and Fortune and Jackpot in the Philippines.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
PMI's Global Innovation Platform Debuts in the U.S.
- U.S. Debut: PMI's global science and innovation platform, Technovation, will debut in the U.S. on April 14, 2026, bringing together experts, policymakers, and business leaders to accelerate the transition to a smoke-free future, marking a significant strategic move for the company in the U.S. market.
- Investment and Expansion: PMI has invested over $16 billion in the U.S. for the development and commercialization of smoke-free products, with over 43 million legal-age consumers currently using its products, demonstrating the company's strong market influence in promoting smoke-free alternatives.
- Market Leadership: PMI's ZYN product is the first nicotine pouch authorized by the FDA in the U.S., establishing itself as a leader in the smoke-free product market, driving changes in consumer behavior, and fostering a responsible brand image in a highly regulated market.
- Scientific and Technological Advancements: The Technovation event will showcase PMI's scientific progress in smoke-free products, emphasizing collaboration with law enforcement to combat illicit trade, further solidifying the company's leadership position in the industry.
See More
Philip Morris Unveils Value Plan 2030+ for Sustainable Growth
- Sustainability Strategy: Philip Morris International (PMI) released its 2025 Value Report, introducing the Value Plan 2030+ aimed at driving the company's transformation towards a smoke-free future through continuous innovation and capital allocation, which is expected to significantly enhance its competitiveness in global markets.
- Strong Financial Performance: PMI's smoke-free products achieved net revenues of $16.9 billion in 2025, representing 41.5% of total annual net revenues, indicating substantial market share growth during the transformation and reinforcing its leadership in consumer health.
- Reduced Environmental Impact: PMI achieved a 46% reduction in greenhouse gas emissions compared to 2019 and reached carbon neutrality in its direct operations by 2025, demonstrating proactive efforts in addressing climate change and enhancing its sustainable brand image.
- Commitment to Social Responsibility: By the end of 2025, 99.6% of contracted farmers achieved a living income, showcasing PMI's success in promoting agricultural sustainability and social responsibility, which further enhances trust and brand loyalty among stakeholders.
See More
Altria Faces Challenges in Tobacco Market
- Stock Performance Review: While Altria has historically achieved an annual return of 20%, its performance over the past decade has been lackluster due to declining smoking rates in the U.S., highlighting the vulnerability of its core business.
- Diversification Failures: Altria's investments in Cronos Group and Juul Labs have resulted in billions in losses, and its recent acquisition of NJOY faced a ban from the U.S. International Trade Commission due to patent infringement, exacerbating financial pressures.
- New Product Sales Growth: Despite the decline in its core business, Altria's On! oral nicotine pouches saw an 11% increase in sales to 177.8 million cans over the past year, but a drop in market share indicates competitive pressures, particularly from Philip Morris's Zyn.
- Future Earnings Outlook: Altria projects earnings per share growth of 2.5% to 5.5%, reaching $5.56 to $5.72 in 2026, and with a 6.3% dividend yield, it still presents some investment appeal despite the risks associated with its declining core business.
See More
Altria's Diversification Efforts Falter
- Core Business Decline: Altria has managed profit growth by raising cigarette prices, yet its 2025 revenue after excise taxes fell 1.5% to $20.1 billion, indicating a persistent decline in its core business and significant risks for future growth.
- New Product Market Competition: Altria's On! oral nicotine pouches saw an 11% shipment increase to 177.8 million cans over the past year, but a decline in market share in Q4 due to Zyn's promotions suggests limited market acceptance for new products.
- Shareholder Returns and Risks: Despite a roughly 50% stock price increase over the past two years, Altria's 2026 earnings per share target of $5.56 to $5.72, combined with a 6.3% dividend yield, highlights the challenges and uncertainties the company faces during its transition.
- Uncertain Industry Outlook: With smoking rates among young Americans continuing to decline, Altria's cigarette sales are almost certain to keep falling, and if the company cannot replace lost profits with new products, its long-term stock price will face downward pressure.
See More
PMI U.S. INTRODUCES TECHNOVATION IN WASHINGTON D.C.
Innovation in Washington D.C.: The article discusses the introduction of new technologies and innovations in Washington D.C., highlighting their potential impact on various sectors.
Focus on Sustainability: Emphasis is placed on sustainable practices and how they are being integrated into the technological advancements being implemented in the city.
Collaboration with Tech Companies: The piece outlines partnerships between government entities and tech companies to foster innovation and improve public services.
Future Prospects: It concludes with a look at the future of technology in Washington D.C., suggesting that ongoing innovation will play a crucial role in the city's development.
See More
Tobacco Industry Faces Challenges and Transformation
- Cigarette Volume Pressure: The tobacco industry is facing significant challenges with a notable decline in cigarette sales due to inflation and changing consumer preferences, with traditional cigarettes still being a major revenue source, making the ongoing sales decline a considerable threat to the industry.
- Cost Increase Risks: Industry participants are under pressure from high costs associated with key inputs such as tobacco leaf, energy, and labor, while simultaneously increasing investments in the research, development, and commercialization of smoke-free products, further squeezing profit margins.
- Popularity of Smoke-Free Products: With rising health awareness and stricter regulatory frameworks, consumers are increasingly shifting towards smoke-free alternatives like heated tobacco, vapor products, and oral nicotine, driving a gradual transformation in the industry's revenue mix.
- Market Performance Weakness: Despite the tobacco industry growing by 16.1% over the past year, it still underperformed compared to the S&P 500's 18.7% growth, indicating relative weakness within the overall market.
See More
PMI's Global Innovation Platform Debuts in the U.S.
- U.S. Debut: PMI's global science and innovation platform, Technovation, will debut in the U.S. on April 14, 2026, bringing together experts, policymakers, and business leaders to accelerate the transition to a smoke-free future, marking a significant strategic move for the company in the U.S. market.
- Investment and Expansion: PMI has invested over $16 billion in the U.S. for the development and commercialization of smoke-free products, with over 43 million legal-age consumers currently using its products, demonstrating the company's strong market influence in promoting smoke-free alternatives.
- Market Leadership: PMI's ZYN product is the first nicotine pouch authorized by the FDA in the U.S., establishing itself as a leader in the smoke-free product market, driving changes in consumer behavior, and fostering a responsible brand image in a highly regulated market.
- Scientific and Technological Advancements: The Technovation event will showcase PMI's scientific progress in smoke-free products, emphasizing collaboration with law enforcement to combat illicit trade, further solidifying the company's leadership position in the industry.
See More
Philip Morris Unveils Value Plan 2030+ for Sustainable Growth
- Sustainability Strategy: Philip Morris International (PMI) released its 2025 Value Report, introducing the Value Plan 2030+ aimed at driving the company's transformation towards a smoke-free future through continuous innovation and capital allocation, which is expected to significantly enhance its competitiveness in global markets.
- Strong Financial Performance: PMI's smoke-free products achieved net revenues of $16.9 billion in 2025, representing 41.5% of total annual net revenues, indicating substantial market share growth during the transformation and reinforcing its leadership in consumer health.
- Reduced Environmental Impact: PMI achieved a 46% reduction in greenhouse gas emissions compared to 2019 and reached carbon neutrality in its direct operations by 2025, demonstrating proactive efforts in addressing climate change and enhancing its sustainable brand image.
- Commitment to Social Responsibility: By the end of 2025, 99.6% of contracted farmers achieved a living income, showcasing PMI's success in promoting agricultural sustainability and social responsibility, which further enhances trust and brand loyalty among stakeholders.
See More
Altria Faces Challenges in Tobacco Market
- Stock Performance Review: While Altria has historically achieved an annual return of 20%, its performance over the past decade has been lackluster due to declining smoking rates in the U.S., highlighting the vulnerability of its core business.
- Diversification Failures: Altria's investments in Cronos Group and Juul Labs have resulted in billions in losses, and its recent acquisition of NJOY faced a ban from the U.S. International Trade Commission due to patent infringement, exacerbating financial pressures.
- New Product Sales Growth: Despite the decline in its core business, Altria's On! oral nicotine pouches saw an 11% increase in sales to 177.8 million cans over the past year, but a drop in market share indicates competitive pressures, particularly from Philip Morris's Zyn.
- Future Earnings Outlook: Altria projects earnings per share growth of 2.5% to 5.5%, reaching $5.56 to $5.72 in 2026, and with a 6.3% dividend yield, it still presents some investment appeal despite the risks associated with its declining core business.
See More
Altria's Diversification Efforts Falter
- Core Business Decline: Altria has managed profit growth by raising cigarette prices, yet its 2025 revenue after excise taxes fell 1.5% to $20.1 billion, indicating a persistent decline in its core business and significant risks for future growth.
- New Product Market Competition: Altria's On! oral nicotine pouches saw an 11% shipment increase to 177.8 million cans over the past year, but a decline in market share in Q4 due to Zyn's promotions suggests limited market acceptance for new products.
- Shareholder Returns and Risks: Despite a roughly 50% stock price increase over the past two years, Altria's 2026 earnings per share target of $5.56 to $5.72, combined with a 6.3% dividend yield, highlights the challenges and uncertainties the company faces during its transition.
- Uncertain Industry Outlook: With smoking rates among young Americans continuing to decline, Altria's cigarette sales are almost certain to keep falling, and if the company cannot replace lost profits with new products, its long-term stock price will face downward pressure.
See More
PMI U.S. INTRODUCES TECHNOVATION IN WASHINGTON D.C.
Innovation in Washington D.C.: The article discusses the introduction of new technologies and innovations in Washington D.C., highlighting their potential impact on various sectors.
Focus on Sustainability: Emphasis is placed on sustainable practices and how they are being integrated into the technological advancements being implemented in the city.
Collaboration with Tech Companies: The piece outlines partnerships between government entities and tech companies to foster innovation and improve public services.
Future Prospects: It concludes with a look at the future of technology in Washington D.C., suggesting that ongoing innovation will play a crucial role in the city's development.
See More
Tobacco Industry Faces Challenges and Transformation
- Cigarette Volume Pressure: The tobacco industry is facing significant challenges with a notable decline in cigarette sales due to inflation and changing consumer preferences, with traditional cigarettes still being a major revenue source, making the ongoing sales decline a considerable threat to the industry.
- Cost Increase Risks: Industry participants are under pressure from high costs associated with key inputs such as tobacco leaf, energy, and labor, while simultaneously increasing investments in the research, development, and commercialization of smoke-free products, further squeezing profit margins.
- Popularity of Smoke-Free Products: With rising health awareness and stricter regulatory frameworks, consumers are increasingly shifting towards smoke-free alternatives like heated tobacco, vapor products, and oral nicotine, driving a gradual transformation in the industry's revenue mix.
- Market Performance Weakness: Despite the tobacco industry growing by 16.1% over the past year, it still underperformed compared to the S&P 500's 18.7% growth, indicating relative weakness within the overall market.
See More
